Asset Details
Do you wish to reserve the book?
Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review
Do you wish to request the book?
Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review
2020
Overview
Oxidative stress is significantly involved in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). Combining antioxidant drugs or nutrients results in a noteworthy therapeutic value in animal models of COPD. However, the benefits have not been reproduced in clinical applications, this may be attributed to the limited absorption, concentration, and half-life of exogenous antioxidants. Therefore, novel drug delivery systems to combat oxidative stress in COPD are needed. This review presents a brief insight into the current knowledge on the role of oxidative stress and highlights the recent trends in novel drug delivery carriers that could aid in combating oxidative stress in COPD. The introduction of nanotechnology has enabled researchers to overcome several problems and improve the pharmacokinetics and bioavailability of drugs. Large porous microparticles, and porous nanoparticle-encapsulated microparticles are the most promising carriers for achieving effective pulmonary deposition of inhaled medication and obtaining controlled drug release. However, translating drug delivery systems for administration in pulmonary clinical settings is still in its initial phases.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analysis
/ Animals
/ Chemistry and Materials Science
/ Chronic obstructive pulmonary disease
/ Drug Carriers - pharmacology
/ Drugs
/ Humans
/ Nanocomposite microparticles
/ Nanoparticles - therapeutic use
/ Oxidative Stress - drug effects
/ Pulmonary Disease, Chronic Obstructive - drug therapy
/ Review
/ Vehicles
